Ryan Braun AP

No, the Biogenesis thing does not cast us adrift on a sea of uncertainty

25 Comments

Danny Knobler wrings his hands:

Ryan Braun, you’re doing it to us again. Leaving us wondering. Leaving us asking questions. Leaving us in that zone of uncertainty that we’d hoped we had left behind, when baseball and its players union finally stopped looking the other way on steroids.

Drug testing was supposed to clean up the game, but it was also supposed to give us clarity. It was supposed to give us trust that we could believe what we were watching. Some players would fail tests, but they would be suspended and we would know who they were.

Now we’re back to where we were before testing began. We’re back with suspicions and reports.

You’re only there because you want to be, Danny.

If you think we’re in a land of pre-testing uncertainty — which Knobler specifically says later in his column — then the current drug testing program is utterly meaningless. He should just advocate for it being scrapped, because it’s giving him no comfort whatsoever.  For my part, I read just about everything Danny Knobler writes, and I’ve never once seen him claim that the current drug testing program is pointless and should be abandoned.

To the contrary. Last year, after Braun’s appeal, Knobler was one of the few voices who accepted the results and defended Braun and the process.  He believed in it then and said that Braun was due the benefit of the doubt because of the system. Why is he not owed the benefit of the doubt now? Why is the system of no comfort to Knobler today when it was in late February 2012?

Since that decision, the loophole through which Braun and his lawyers jumped has been closed and MLB and MLBPA have increased the stringency of the drug testing program. Indeed, even the USADA and WADA are now applauding it as U.S. team sports’ most rigorous drug testing regime. On the other hand, we’re have one report of currently uncertain weight and import involving a few players, several of which aren’t tied to PEDs.

Maybe that report turns into something big. Maybe it turns into nothing. But that’s what we have.  We do not have the end of all certainty regarding baseball and drugs. We are not cast adrift on a sea of doubt like Knobler will have you believe. Or, as of a year ago, as he even believed.

Report: Dexter Fowler will take a physical in St. Louis on Friday

CLEVELAND, OH - NOVEMBER 02:  Dexter Fowler #24 of the Chicago Cubs reacts after lining out during the third inning against the Cleveland Indians in Game Seven of the 2016 World Series at Progressive Field on November 2, 2016 in Cleveland, Ohio.  (Photo by Ezra Shaw/Getty Images)
Ezra Shaw/Getty Images
9 Comments

Update (8:51 PM EST): The deal is in place, according to Heyman.

*

Update (8:27 PM EST): Derrick Goold of the St. Louis Post-Dispatch reports that the Cardinals made an “over-the-top offer” to Fowler to ensure he’d sign.

*

Frank Cusumano of KSDK Sports reports that free agent outfielder will take a physical in St. Louis on Friday. Presumably, that means that Fowler and the Cardinals have gotten pretty far along in negotiations.

Jon Heyman of FanRag Sports recently reported that Fowler was looking for $18 million per year. The Blue Jays reportedly made an offer to Fowler in the four-year, $16 million range several days ago. The Cardinals’ offer to Fowler, if there is indeed one, is likely somewhere between the two figures.

Fowler, 30, is coming off of a fantastic year in which he helped the Cubs win their first World Series since 1908. During the regular season, he hit .276/.393/.447 with 13 home runs, 48 RBI, 84 runs scored, and 13 stolen bases in 551 plate appearances.

Fowler rejected the Cubs’ $17.2 million qualifying offer last month. While the QO compensation negatively affected Fowler’s experience in free agency last offseason — he didn’t sign until late February with the Cubs — his strong season is expected to make QO compensation much less of an issue.

Braves acquire Luke Jackson from the Rangers

ARLINGTON, TX - SEPTEMBER 16:  Relief pitcher Luke Jackson #53 of the Texas Rangers  throws during the ninth inning of a baseball game against the Houston Astros at Globe Life Park on September 16, 2015 in Arlington, Texas. Texas won 14-3. (Photo by Brandon Wade/Getty Images)
Brandon Wade/Getty Images
Leave a comment

Tommy Stokke of RanRag Sports reports that the Braves and Rangers agreed to a trade. According to ESPN’s Keith Law, the Braves will receive pitcher Luke Jackson from the Rangers in exchange for pitchers Tyrell Jenkins and Brady Feigl.

Jackson, 25, is under team control through 2022. He has logged only 18 innings in the majors, yielding 14 runs on 22 hits and eight walks with three strikeouts. While Jackson has struggled with control, the Braves likely see upside because his fastball sits in the mid- to high-90’s.

Jenkins, 24, is also under team control through 2022. The right-hander made eight starts and six relief appearances in his first major league season in 2016, putting up a 5.88 ERA with a 26/33 K/BB ratio over 52 innings.

Feigl, 25, was an undrafted free agent and was signed by the Braves in 2013. The lefty underwent Tommy John surgery in 2015 and briefly rehabbed in rookie ball this past season.